Today: December 17, 2018, 12:16 am
  
Business

Cypress Development Announces $1.1 million Private Placement

PR-Inside.com: 2018-10-11 14:04:02

“NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES”

VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V: CYP) (OTCQB: CYDVF) (Frankfurt: C1Z1) (“Cypress” or the “Company”) announces a non-brokered private placement of up to 5,000,000 Units at a price of $0.22 per Unit to raise gross proceeds of up to $1,100,000. Each Unit will consist of one common share of the Company and one share purchase Warrant entitling the holder to purchase an additional common share at a price of $0.33 for a period of three years.

Proceeds of the offering will finance the completion of a prefeasibility study (PFS) for Cypress’ Clayton Valley Lithium Project in Nevada, including further metallurgical studies, related infill drilling, and for general working capital purposes. Dr. Bill Willoughby, Chief Executive Officer, commented: "Cypress is pleased to be able to fund the Clayton Valley Project’s next steps with a modest capital outlay. The undertaking of infill drilling, further metallurgical studies and a prefeasibility study to provide more detailed information related to the project's economic assumptions hold the potential to unlock significant shareholder value."

Finder's fees may be paid in connection with part of this private placement offering. The private placement is subject to TSX Venture Exchange acceptance.

About Cypress Development Corp.:

Cypress Development Corp. is a publicly traded exploration company focused on developing the Company's 100%-owned Clayton Valley Lithium Project in Nevada. Exploration and development by Cypress has discovered a world-class resource of lithium-bearing claystone adjacent to Albemarle's Silver Peak mine, North America's only lithium brine operation.

Cypress Development Corp. has approx. 62.7 million shares issued and outstanding.

To find out more about Cypress Development Corp. (TSX-V: CYP), visit our website at www.cypressdevelopmentcorp.com.

CYPRESS DEVELOPMENT CORP.

“Dr. Bill Willoughby”
______________________________
WILLIAM WILLOUGHBY, PhD., PE
Chief Executive Officer

For further information contact myself or:
Don Myers
Cypress Development Corp.
Director, Corporate Communications
Telephone: 604-639-3851
Toll Free: 800-567-8181
Facsimile: 604-687-3119
Email: info@cypressdevelopmentcorp.com 

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THE CONTENT OF THIS NEWS RELEASE.

This release includes certain statements that may be deemed to be "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that management of the Company expects, are forward-looking statements. Although management believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual results or developments may differ materially from those in the forward-looking statements. The Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change. Factors that could cause actual results to differ materially from those in forward-looking statements, include market prices, exploration and development successes, continued availability of capital and financing, and general economic, market or business conditions. Please see the public filings of the Company at www.sedar.com for further information.




# 806 Words
Related Articles
More From The Author
BlissCo signs LOI to Acquire Pre-Approved Medical [..]
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- BlissCo [..]
iCAD Announces Exceptional Study Results Demonstrating Significant [..]
Results demonstrate unprecedented improvements in clinical performance and reading times, validating the substantial benefits of [..]
Invitation to Suominen’s Q3 analyst and press [..]
Suominen Corporation     Investor News     11 October 2018 at 3:00 pm (EEST) Invitation to Suominen’s Q3 analyst and [..]
ProMIS Neurosciences Identifies Novel Antibody Drug Candidates [..]
Unique discovery platform generates new antibody candidates that block a root cause of Parkinson’s DiseaseTORONTO and CAMBRIDGE, [..]
Biogen Advances Research to Improve Outcomes for [..]
Evidence supports potential of serum neurofilament light (sNfL) as clinically useful biomarker in MS; Biogen and Siemens Healthineers [..]
 
More From Business
Learn about Dishonest Companies and Specialist on [..]
12 December 2018 – Beware.org provides the most favorable conditions for average consumers to publish the alerts and warnings about [..]
Brands Reviews Offers the Best Quality Reviews
12 December 2018 – Brands Reviews is offering the largest collection of reliable and trusted qqtube review and subpals review [..]
509 Electric Is the Best Residential Electrical [..]
Yakima, USA – 12 December 2018 – 509 Electric is the best Yakima Electrical Contractor ready to offer top quality [..]
Cross Talks Awarded $5K Grant from the [..]
The Penn State Brandywine Boost, a program of the Invent Penn State initiative, has selected Delaware State Chamber Member, Soraya [..]
Huber Needles: Market is likely to register [..]
This Market Study provides key insights and forecast on the global Huber needles market for the forecast period 2017-2024. The [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.